About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prevention of Asthma Relapse After Discharge From Emergency

Prevention of Asthma Relapse After Discharge From Emergency

NCT00326053·20 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

18 - 65 years of age
Presenting at a study emergency department with an asthma exacerbation

You may not be if

Admission to hospital
Patients receiving more than 2000 µg/day of beclomethasone equivalent inhaled corticosteroids (1000 µg/day fluticasone or 1600 µg/day budesonide)

The record

StatusCompleted

PhasePhase 3

Taking part600

StartedMay 2006

UpdatedJan 24, 2011

Conditions

Where20

Research Site
Calgary, Alberta, Canada
Research Site
Edmonton, Alberta, Canada
Research Site
Lethbridge, Alberta, Canada